Publications by authors named "Kathleen Haskell"

Claim this Profile
A
A Strategy for Selective Deletion of Autoimmunity-Related T Cells by pMHC-Targeted Delivery.
Shalom D Goldberg, Nathan Felix, Michael McCauley, Ryan Eberwine, Lou Casta, Kathleen Haskell

Pharmaceutics· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Centyrin ligands for extrahepatic delivery of siRNA.
Donna Klein, Shalom Goldberg, Christopher S Theile, Richard Dambra, Kathleen Haskell

Mol Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Cy-5 siRNA signal in the intra-vital multi-photon microscopy images.
Antong Chen, Belma Dogdas, Saurin Mehta, Kathleen Haskell, Bruce Ng

Annu Int Conf IEEE Eng Med Biol Soc· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo.
Craig Cherrin, Kathleen Haskell, Bonnie Howell, Raymond Jones, Karen Leander

Cancer Biol Ther· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.
Qing-Bai She, Sarat Chandarlapaty, Qing Ye, Jose Lobo, Kathleen M Haskell

PLoS One· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model.
Mark T Bilodeau, Adrienne E Balitza, Jacob M Hoffman, Peter J Manley, Stanley F Barnett, Kathleen Haskell

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members.
Deborah DeFeo-Jones, Stanley F Barnett, Sheng Fu, Paula J Hancock, Kathleen M Haskell

Mol Cancer Ther· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.
Stanley F Barnett, Deborah Defeo-Jones, Sheng Fu, Paula J Hancock, Kathleen M Haskell

Biochem J· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prostate-specific antigen (PSA)-activated vinblastine prodrug selectively kills PSA-secreting cells in vivo.
Deborah DeFeo-Jones, Stephen F Brady, Dong-Mei Feng, Bradly K Wong, Trina Bolyar, Kathleen Haskell

Mol Cancer Ther· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis